Skip to main content
  1. Right Decisions
  2. Back
  3. Breast pathways
  4. Breast pain pathway update
Important: please update your RDS app to version 4.7.3 Details with newsletter below.

Please update your RDS app to v4.7.3

We asked you in January to update to v4.7.2.  After the deployment planned for 27th February, this new update will be needed to ensure that you are able to download RDS toolkits even when the RDS website is not available. We will wait until as many users as possible have downloaded the new version before switching off the old system for app downloads and moving entirely to the new approach.

To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. 

To update to the latest release:

 On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Right Decision Service newsletter: February 2025

Welcome to the February 2025 update from the RDS team

1.     Next release of RDS

 

A new release of RDS is planned (subject to outcomes of current testing) for week beginning 24th February. This will deliver:

 

  • Fixes to mitigate the recurring glitches with the RDS admin area and the occasional brief user interface outages which have arisen following implementation of the new distributed technology infrastructure in December 2024.

 

  • Capability to embed content from Google calendar, Google Maps, Daily Motion, Twitter feeds, Microsoft Stream into RDS pages.

 

  • Capability to include simple multiplication in RDS calculators.

 

The release will also incorporate a number of small fixes, including:

  • Exporting of form within Medicines Sick Day Guidance in polypharmacy toolkit
  • Links to redundant content appearing in search in some RDS toolkits
  • Inclusion of accordion headers alongside accordion text in search result snippets.
  • Feedback form on mobile app.
  • Internal links on mobile app version of benzo tapering tool

 

We will let you know when the date and time for the new release are confirmed.

 

2.     New RDS developments

There is now the capability to publish toolkits on the web with left hand side navigation rather than tiles on the homepage. To use this feature, turn on the “Toggle navigation panel” option at the top of the Page settings menu at toolkit homepage level – see below. Please note that publication to downloadable mobile app for this type of navigation is still under development.

The Benzodiazepine tapering tool is now available as part of the RDS toolkit for the national benzodiazepine prescribing guidance developed by the Scottish Government Effective Prescribing team. The tool uses this national guidance developed with a wide-ranging multidisciplinary group. This should be used in combination with professional judgement and an understanding of the needs of the individual patient.

3.     Archiving and version control and new RDS Search and Browse interface

Due to the intensive work Tactuum has had to undertake on the new technology infrastructure has pushed back the delivery dates again and some new requirements have come out of the recent user acceptance testing. It now looks likely to be an April release for the search and browse interface. The archiving and version control functionality may be released earlier. We’ll keep you posted.

4.     Statistics

At the end of January, Olivia completed the generation of the latest set of usage statistics for all RDS toolkits. If you would like a copy of the stats for your toolkit, please contact Olivia.graham@nhs.scot .

 

5.     Review of content past its review date

We have now generated reports of all RDS toolkit content that has exceeded its review date by 6 months or more. We will be in touch later this month with toolkit owners and editors to agree the plan for updating or withdrawing out of date content.

 

6.     Toolkits in development

Some important toolkits in development by the RDS team include:

  • National CVD prevention pathways – due for release end of March 2025.
  • National respiratory pathways, optimal cancer diagnostic pathways and cancer prehabilitation pathways from the Centre for Sustainable Delivery. We will shortly start work on the national cancer referral pathways, first version due for release via RDS around end of June 2025.
  • HIS Quality of Care Review toolkit – currently in final stages of quality assurance.

 

The RDS team and other information scientists in HIS have also been producing evidence summaries for the Scottish Government Realistic Medicine team, to inform development of national guidance around Procedures of Limited Clinical Value. This guidance will in due course be translated into an RDS toolkit.

 

7. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:

  • Friday 28th February 12-1 pm
  • Tuesday 11th March 4-5 pm

 

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

 

To invite colleagues to sign up to receive this newsletter, please signpost them to the registration form  - also available in End-user and Provider sections of the RDS Learning and Support area.   If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

 

 

Breast pain pathway update

Warning

The Symptomatic Breast Pain Specialty Delivery Group published the Breast Pain Pathway in 2022.

While breast pain accounts for 15% of all clinical referrals, almost all people who are referred with breast/axillary pain have chest wall pain unrelated to the breast itself.

The pathway covers advice for healthcare professionals in relation to the following:

  • Imaging for Breast Pain (based on best available evidence)
  • Referral to Secondary Care
  • Management of patients with breast pain within primary care

Click the play button below to find out more about breast pain.

 

Remit

In 2019 the Scottish Access Collaborative Development Group (Breast) met to discuss themes that could be developed to sustainably improve waiting times for non-urgent care within breast services.

This work has been progressed through the Modernising Patient Pathways Programme Symptomatic Breast Group to focus on delivering services in an effective, patient-centred way and is based on the NICE clinical knowledge summary (CKS) on cyclical breast pain.1

The recommendations have not followed the standard process used by SIGN to develop guidelines. They are based on available guidance and expert opinion, with fast peer review as assurance.

This guidance will be reviewed and updated as new evidence emerges.

 

Recommendations

A common theme during these meetings has been a focus on the referral of breast pain to secondary care services. A consensus was formed around two principles that:

  1. There has been an increasing medicalisation of the symptom of breast pain, despite this being usually an entirely normal physiological process. Breast pain is the main factor in around 15% of all symptomatic breast clinic referrals leading to over investigation.
  2. Almost all people who are referred with breast/axillary pain have chest wall pain unrelated to the breast itself.

The Modernising Patient Pathway Programme Symptomatic Breast Group was tasked to discuss current and proposed practice and to develop recommendations for the management of people with breast pain. It is important to note that these recommendations are for patients with breast pain only and with no other worrying symptoms or signs on presentation (details of such signs and symptoms are provided in the NICE CKS).1,2

The recommendations fall into three groups:

1.   Imaging for breast pain

  1. Currently there is a widespread difference between, and within, Scottish breast units with regard to imaging patients with breast pain; with some imaging no patients, some all patients and some using it as an opportunity for screening.

We suggest that:

  1. There is no indication for imaging patients with breast pain in the absence of any other symptoms or signs
  2. If patients have missed screening appointments they should be directed to the appropriate screening pathway to be included within a fully quality-assured programme, and opportunistic screening within symptomatic practice is not recommended
  3. If units wish to image patients with breast pain it may be worth auditing this pathway to see if the incidence of cancers differs from an age-matched screening population.

 

2.  Referral to secondary care

We suggest that patients with symptoms of breast pain, whether pre- or postmenopausal, can be reassured that this a normal process, usually settles of its own accord and are directed to symptomatic relief advice. Ideally, this reassurance would be provided through public messaging on NHS and third-sector platforms without necessitating a need to be seen in primary care.3

Patients who are referred to secondary care should:

  • have intractable severe unifocal postmenopausal breast (not chest wall or axillary) pain
  • have had 3 months’ trial of conservative advice management
  • appreciate that further management options, apart from analgesia, are very limited.

The very small number of patients with breast pain requiring referrals to secondary care do not necessarily need to be managed in rapid access clinics but instead could be given:

  • written advice which is also shared with their GP
  • a telephone/Near me appointment with specialist nurses
  • an appointment in a low risk/benign clinic.

 

3.   Management of patients with breast pain within primary care practice

  1. Patients experiencing breast or chest wall pain can be strongly reassured that in the absence of any other symptoms or findings that this is normal, usually self limiting and not linked with malignancy.
  2. Most postmenopausal breast pain is actually chest wall in origin and patients can be reassured accordingly.
  3. Conservative management advice should include a well-fitted supportive bra and regular use of topical NSAIDs massaged into the symptomatic area on the chest wall.

 

Development Group Members

  • Matthew Barber - Consultant Breast Surgeon, NHS Lothian
  • Ian Daltrey - Consultant Breast Surgeon, NHS Highland
  • Mike McKirdy - Consultant Breast Surgeon, NHS Greater Glasgow & Clyde
  • Rachel Meney - Surgical Nurse Practitioner, NHS Greater Glasgow & Clyde
  • Sian Tovey - Consultant Breast Surgeon, NHS Ayrshire and Arran and Chair of the group

 

Editorial Information

Last reviewed: 01/06/2022

Next review date: 01/03/2026

Author(s): Modernising Patient Pathways Programme Symptomatic Breast Group.

Version: 2.0

Approved By: Centre for Sustainable Delivery

Reviewer name(s): Centre for Sustainable Delivery.